Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection.

Elajouz B, Dumkow LE, Worden LJ, VanLangen KM, Jameson AP

Open source

DOI: 10.1017/ash.2022.317
Published: 2022
Container: Antimicrobial stewardship & healthcare epidemiology : ASHE
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1017/ash.2022.317,
  title = {Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection.},
  author = {Elajouz B and Dumkow LE and Worden LJ and VanLangen KM and Jameson AP},
  year = {2022},
  journal = {Antimicrobial stewardship \& healthcare epidemiology : ASHE},
  doi = {10.1017/ash.2022.317},
  url = {https://doi.org/10.1017/ash.2022.317}
}

RIS

TY  - JOUR
TI  - Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection.
AU  - Elajouz B
AU  - Dumkow LE
AU  - Worden LJ
AU  - VanLangen KM
AU  - Jameson AP
PY  - 2022
JO  - Antimicrobial stewardship & healthcare epidemiology : ASHE
DO  - 10.1017/ash.2022.317
UR  - https://doi.org/10.1017/ash.2022.317
ER  -

APA

B, E., LE, D., LJ, W., KM, V., & AP, J. (2022). Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection.. Antimicrobial stewardship & healthcare epidemiology : ASHE. https://doi.org/10.1017/ash.2022.317

Source records

pubmed · retrieved 2026-09-25T16:30:50.152Z
europe-pmc · retrieved 2026-09-25T16:30:50.170Z
doaj · retrieved 2026-09-25T16:30:50.165Z